GPI S.p.A. (BIT:GPI)
15.20
+0.32 (2.15%)
Oct 16, 2026, 5:35 PM CET
GPI S.p.A. Revenue
GPI S.p.A. had revenue of 256.45M EUR in the half year ending June 30, 2026, with 8.47% growth. This brings the company's revenue in the last twelve months to 543.23M, up 1.86% year-over-year. In the year 2025, GPI S.p.A. had annual revenue of 546.18M with 7.02% growth. That makes GPI S.p.A. the 10,121st largest company in the world by revenue and 105th in Italy.
Revenue (ttm)
543.23M
Revenue Growth
+1.86%
P/S Ratio
0.79
Revenue / Employee
79.69K
Employees
7,834
Market Cap
439.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 546.18M | 35.84M | 7.02% |
| Dec 31, 2024 | 510.34M | 76.92M | 17.75% |
| Dec 31, 2023 | 433.42M | 86.42M | 24.90% |
| Dec 31, 2022 | 347.01M | 20.22M | 6.19% |
| Dec 31, 2021 | 326.79M | 55.77M | 20.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.71B |
| Amplifon | 2.40B |
| DiaSorin | 1.18B |
| Safilo Group | 957.72M |
| EL.En. | 611.40M |
| Garofalo Health Care | 493.80M |
| Philogen | 315.27M |
| Pharmanutra | 143.70M |
GPI S.p.A. News
- 14 days ago - GPI S.p.A. Earnings Call Transcript: H1 2026 - Transcripts
- 14 days ago - GPI S.p.A. Earnings release: H1 2026 - Filings
- 14 days ago - GPI S.p.A. Slides: H1 2026 - Filings
- 6 months ago - GPI S.p.A. Earnings release: H2 2025 - Filings
- 6 months ago - GPI S.p.A. Slides: H2 2025 - Filings
- 6 months ago - GPI S.p.A. Annual report: H2 2025 - Filings